Page last updated: 2024-10-23

seratrodast and Cough

seratrodast has been researched along with Cough in 1 studies

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research Excerpts

ExcerptRelevanceReference
"The effects of the orally active thromboxane A2 (TxA2) receptor antagonist seratrodast and the cysteinyl leukotrienes (cLTs) receptor antagonist pranlukast on cough response to inhaled capsaicin were examined in sixteen patients with stable chronic bronchitis."5.10Thromboxane antagonism and cough in chronic bronchitis. ( Fujimura, M; Ishiura, Y; Kurashima, K; Myou, S; Nobata, K; Takegoshi, T; Yamamori, C, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiura, Y1
Fujimura, M1
Yamamori, C1
Nobata, K1
Myou, S1
Kurashima, K1
Takegoshi, T1

Trials

1 trial available for seratrodast and Cough

ArticleYear
Thromboxane antagonism and cough in chronic bronchitis.
    Annals of medicine, 2003, Volume: 35, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Benzoquinones; Bronchitis; Capsaicin; Chromones; Chronic Disease; Co

2003